Perinucleolar Compartment Prevalence Has an Independent Prognostic Value for Breast Cancer
Authors:
Open Access
- 1 January 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (1) , 246-253
Abstract
The perinucleolar compartment (PNC) is a multicomponent nuclear structure enriched with RNAs transcribed by RNA pol III and RNA binding proteins. Studies in cultured cells showed an association between PNC and transformed phenotype. To evaluate the relationship between structure and malignancy in vivo, we examined PNC prevalence (the percentage of cells containing at least one PNC) in normal and cancerous paraffin-embedded breast tissues using immunohistochemistry against a PNC-associated protein. Five hundred nuclei in the most active area of each sample were scored for PNC prevalence. The results show that PNC prevalence significantly correlates with the progression of breast cancer (by the criteria of staging). PNC prevalence in primary tumors, lymph nodes, and distant metastases shows a stepwise increase from a median of 23% in primary tumors to ∼100% in distant metastases. In addition, univariate and multivariate (controlling for tumor size and grade) analyses show that early-stage patients with invasive ductal carcinomas containing a higher PNC prevalence have a significantly poorer prognosis. These findings link PNC prevalence with the progression of breast cancer in vivo and suggest that PNC-containing cells have metastatic advantages. These findings also show the potential of PNC prevalence as a prognostic marker for breast cancer.Keywords
This publication has 29 references indexed in Scilit:
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- RNA Polymerase III Transcripts and the PTB Protein Are Essential for the Integrity of the Perinucleolar CompartmentMolecular Biology of the Cell, 2003
- Towards optimal management of ductal carcinoma in situ of the breastEuropean Journal of Surgical Oncology, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Raver1, a dual compartment protein, is a ligand for PTB/hnRNPI and microfilament attachment proteinsJournal of Cell Biology, 2001
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI: Journal of the National Cancer Institute, 2001
- Review: Perinucleolar StructuresJournal of Structural Biology, 2000
- Apoptosis in ductal carcinoma in situ of the breast: its relationship to prognostic markersEuropean Journal of Cancer, 1998
- A perinucleolar compartment contains several RNA polymerase III transcripts as well as the polypyrimidine tract-binding protein, hnRNP I [published erratum appears in J Cell Biol 1995 Jul;130(2):497-500]Journal of Cell Biology, 1995
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991